Protease-activate receptors (PARs) mediate activation of platelets and other cells by thrombin and other proteases. Such protease-triggered signaling events are thought to be critical for hemostasis, thrombosis, and other normal and pathological processes. We report here the structure of the mouse and human PAR3 genes as well as the organization of a PAR gene cluster encompassing the genes encoding PARs 1, 2, and 3. We also report the structure of the mouse and human PAR4 genes, which map to distinct chromosomal locations and encode a new thrombin receptor. PARs 1-4 are all encoded by genes with the same two exon structure. In each case, exon 1 encodes a signal peptide, and exon 2 encodes the mature receptor protein. These are separated by an intron of variable size. The genes encoding PARs 1-3 all map to chromosome 13D2 in mouse and chromosome 5q13 in human. In mouse, all three genes are located within 80 kilobases of each other. The PAR1 gene is located centrally and is flanked upstream by the PAR3 gene and downstream by the PAR2 gene in both species. The proximity of the PAR1 and PAR3 genes suggests the possibility that these genes might share regulatory elements. A comparison of the structures of the PAR amino acid sequences, gene structures, locus organization, and chromosomal locations suggests a working model for PAR gene evolution.
1 mediate cellular responses to thrombin and other proteases in diverse cell types, including platelets. The actions of PARs are thought to be critical for normal hemostasis and in embryonic development and PARs may play important roles in proliferative and inflammatory responses and other physiological processes. PAR1, a thrombin receptor, is prototypical for this subfamily of G protein-coupled receptors. Thrombin activates PAR1 by binding to and cleaving its amino-terminal exodomain; cleavage unmasks a new amino terminus that serves as a tethered ligand, binding intramolecularly to the body of the receptor to effect transmembrane signaling. The synthetic peptide SFLLRN, which mimics this new amino terminus, can activate PAR1 independent of receptor cleavage and thrombin.
PAR2, a receptor for trypsin and trypsin-like enzymes, was identified during a search for substance K receptor relatives (1, 2) . The gene encoding PAR2 (Par2g) was found to share a common structure and chromosomal location with that encoding PAR1 (Par1g) (3, 4) . This observation raised the possibility of a PAR gene cluster containing more novel protease-activated receptor genes. Two new thrombin receptors, PAR3 and PAR4, were recently identified (5, 6) . Whether the genes encoding PAR3 and PAR4 share a common structure and chromosomal location with Par1g and Par2g is unknown.
An apparent species difference in the roles of distinct PARs in platelets invites us to question the evolutionary relationship of these genes and motivates an interest in their structures and locations. PAR1 appears to be important for human platelet activation by thrombin. PAR1 mRNA and protein were detected in human platelets (7) (8) (9) , PAR1-activating peptide caused human platelets to undergo aggregation and secretion (7, 10, 11) , and PAR1-blocking antibodies attenuated human platelet activation by thrombin (8, 9) . In contrast, PAR1 expression was not detected in mouse platelets, PAR1-activating peptide had no effect on mouse platelets (13) , and platelets from PAR1-deficient mice responded to thrombin in a manner indistinguishable from wild type mouse platelets (14) . Thus, PAR1 is important for activation of human platelets but appears to play little or no role in mouse platelets.
The observations cited above prompted a search for new mouse platelet thrombin receptors and led to the identification of PAR3. PAR3 mRNA and protein were detected in mouse megakaryocytes and platelets, respectively (5, 15) , PAR3-blocking antibodies attenuated thrombin signaling (15) , and thrombin responses in platelets from PAR3-deficient mice were markedly diminished but still present at high thrombin concentrations (6) . Thus, PAR3 is necessary for normal thrombin responses in mouse platelets, much like PAR1 in human platelets. Whether PAR3 plays a role in human platelet activation is as yet unknown. The possibility that PAR3 may play distinct tissue-specific roles in mouse and human is raised by its distinct expression patterns: PAR3 expression appears to be limited to megakaryocytes in mouse but is detected in other tissues, such as heart and gut, in human.
The diminished thrombin responses that persisted in PAR3-deficient platelets were not attributable to PAR1, providing genetic evidence for the existence of another thrombin receptor (6) . We and others have recently reported the cloning of a novel thrombin-activated PAR, PAR4, which may account for residual thrombin signaling in PAR3-deficient mouse platelets and in PAR1-desensitized human platelets (6, 16) .
Toward understanding the evolution of the PAR family and the apparent species differences in their tissue-specific roles, we compared the structures and chromosomal locations of the known PAR genes and characterized the structure of a PAR locus.
EXPERIMENTAL PROCEDURES
Nomenclature-Gene names have been written in accordance with the guidelines proposed by the International Committee on Standardized Genetic Nomenclature for Mice (17) and the Guidelines for Human Gene Nomenclature (18) , e.g. the mouse PAR1 gene is Par1g and the human PAR1 gene is PAR1g. Due to a conflict with other genes already designated using PAR, a g (for "gene") was added such that the protease-activated receptor genes are designated PAR1g, PAR2g, PAR3g, andPAR4g; the numbers are assigned based on order of discovery. Mouse and human protease-activated receptor proteins are designated PAR1, PAR2, PAR3, or PAR4.
Determination of the Structure of the PAR3 and PAR4 Genes-Mouse Par3g was identified by polymerase chain reaction (PCR) in bacterial artificial chromosome (BAC) 8050 (3) using the following primer set: forward, TGTGTCACGCTGCCGTTTAAAATCG; reverse, GATGCCCA-TACAGGTGAGGATG. The primers used to amplify the Par3g intron were as follows: forward, GAAAATCCTTATCTTGGTTGCAG; reverse, CAAAGGTATTTTGGGGACCCCCA. The human PAR3g was identified in yeast artificial chromosome (YAC) 6926 (3) using the following degenerate primer set: forward, CCIGCIAA(C/T)ATIGTIAC(A/C/G/T)(T/C-)T(A/G/C/T)TGG; reverse, (A/G)AAIGGIATIA(G/A)(G/A)AAICC(A/G)A-A(A/G)AA. Conditions were as follows: 95°C for 4 min with manual hot start; 95°C for 1 min, 50°C for 2.5 min, and 72°C for 2 min for 15 cycles; 95°C for 1 min, 50°C for 1 min, and 72°C for 2 min for 35 cycles; and 72°C for 8 min. The primers used for PCR amplification of the PAR3g intron were as follows: forward, ATGAAGCCCTCATCTTTGC-AG; reverse, AGCTCCACGAAAGGTCTTAATGG. BAC 16058 (Genome Systems) containing Par4g was identified using the following PCR primers: forward, CTCACTACTGGACTCTGTTTGGTGG; reverse, TGGGCACATAGGCTCCATAGAG. BAC 18612 (Genome Systems) containing PAR4g was identified using the following PCR primers: forward, CCACCATGCTGCTGATGAAC; reverse, TGCTGGGCACGA-AGAAGGC. The PAR4g intron was amplified using the following PCR primers: forward, AGACCCCCAGCGTCTACGAC; reverse, TCCCGCT-CTCGTCGTAGACG.
Pulsed Field Gel Electrophoresis and Southern Blot Analysis of BAC Genomic Clones-DNA from BAC 8050 was isolated using alkaline lysis and column purification (Qiagen). Restriction endonuclease digestion was performed for 3 h in a final volume of 20 l and subsequently run overnight using a Bio-Rad CHEF-DRII pulsed field electrophoresis apparatus in 1% agarose (SeaPlaque) and 0.5ϫ Tris borate/EDTA. Running conditions were as follows: a field strength of 6 volts/cm, a switch time of 1-10 s, a temperature of 14°C, and a running time of 11-15 h. DNA was then transferred from the gels to a Hybond-N membrane (Amersham Pharmacia Biotech) and analyzed by Southern blotting using high stringency conditions (hybridization at 65°C in 2ϫ saline/sodium phosphate/EDTA, 0.1% SDS overnight and wash at 65°C in 0.1ϫ saline/sodium phosphate/EDTA, 0.1% SDS for 30 min). Analysis of the murine genes in BAC 8050 was performed with 5Ј genomic/exon 1 and exon 2/3Ј-untranslated probes obtained by PCR. 5Јgenomic/exon 1 probe primer sets were as follows. Par1g: forward, AAGCGAACAG-CAAGCCAG; reverse, TCCCAGGTCCTTATGGTTTGTG. Par2g: forward, GCCTATTCAGGACCATTGCTTCTC; reverse, CGGAGTAGCATTT-CTCTCAGGTTTG. Exon 2/3Ј-untranslated probes primer sets were as follows. Par1g: forward, TGTGCTTTCGCCTCCAAGTC; reverse, CAC-AGAACGTGACCACTGTTGG. Par2g: forward, GCCAACTACAAATA-CTGCTTAGG; reverse, TCCTCAAACAGATGAGAAGACG. Par3g: forward, GGGTAATACAGGGAAGGTAAAGACG; reverse, AGTGCTG-AGATTAAAGGCATGAGC.
Analysis of the human genes on YAC 6926 was performed with an equivalent set of 5Ј genomic/exon 1 and exon 2/3Ј-untranslated probes also generated by PCR. 5Ј genomic/exon 1 probe primer sets were as follows. PAR1g: forward, CCCCATCATTTAGCTTCCAAAAGG; reverse, GAAAATCTGCCTAACCAGAGTTGC. PAR 2g: forward, TACG-CTGCTCCTTCGGTTTCC; reverse, TTCTCACCTTGGATGGTGCCAC-TGC. PAR3g: forward, ATGAAAGCCCTCATCTTTGCA; reverse, AAA-GGTCTTAATGGGTAAGGT. Exon2/3Ј-untranslated probe primer sets were as follows. PAR1g: forward, AGAAACCTTCCTGCTGAGCCTC; reverse, GGGTGCTTCCATATCAGAACTGAC. PAR2g: forward, GCC-ATCAACTCATTGTCACTGTC; reverse, GGACCTGGAAAACTCAATA-GGAGG. PAR3g: forward, TCCACCACTTCACAAGTCCTGC; reverse, GAATCAGGGAAGAATGGTCCTTTC.
Preparation of YAC Agarose Plugs-YAC agarose plugs were produced as described (20) . A colony of yeast containing YAC Y6926 was inoculated into AHC medium and grown overnight at 30°C with shaking. Approximately 1 ϫ 10 9 yeast cells were spun down at 2100 ϫ g for 20 min. Cells were washed twice in solution I (1 M sorbitol, 20 mM EDTA, pH 8.0, 14 mM ␤-mercaptoethanol) and resuspended in 600 l of the same buffer plus 6 mg/ml zymolase (ICN) at 40°C. An equal volume of 2% agarose (SeaPlaque, FMC BioProducts) in solution I at 40°C was added to the cells, and yeast cells were transferred to 100-l plug molds (Bio-Rad), with approximately 1 ϫ 10 8 yeast cells per plug. After cooling, the agarose yeast plugs were incubated in solution II (1 M sorbital, 20 mM EDTA, 10 mM Tris, pH 7.5, 14 mM ␤-mercaptoethanol, 1 mg/ml zymolase) for 2 h at 37°C to dissolve their cell walls. Plugs were then incubated overnight at 37°C in 1% dodecyl lithium sulfate, 100 mM EDTA, pH 8.0, 10 mM Tris, pH 8.0, and stored at 4°C in 0.2% laurylsarcosine, 10 mM EDTA, 2 mM Tris, pH 9.5, until ready for use.
RecA-assisted Restriction Endonuclease (RARE) Cleavage of YAC DNA in Agarose Plugs-Site-specific cleavage of DNA using RARE cleavage was performed as described (21, 22) . 50-l agarose blocks were equilibrated in RARE Buffer I (25 mM Tris acetate, pH 7.9, 2 mM magnesium acetate, 1 mM dithiothreitol, 0.5 mM spermidine-trihydrochloride, 500 g/ml acetylated bovine serum albumin) at 4°C. In order to protect the designated EcoRI sites from modification by the EcoRI methylase, plugs were incubated with 0.2 g/ml of protecting oligonucleotide (5Ј oligo, AATAAAGAGAGACGTATAAAAGTTCAAGAATTCT-GTCCAGACTCAAGGGCCCTTTCTCATT; 3Ј oligo, TTTTCAATTTTA-AACATATCCAAGTTTGAATTCCTAAAATTATGGAAACAGATGAAA-AGCC), 8 g/ml RecA protein, 1 mM ATP-␥-S, in a 200-l total volume of RARE Buffer I at 37°C for 1 h. 1 l of 32 mM S-adenosyl methionine plus 10 l of 40 units/l EcoRI methylase were then added, and the mixture was incubated for an additional 2 h at 37°C. SDS was added to a final concentration of 1% to stop the reaction, and plugs were equilibrated in Tris/EDTA, pH 8.0, to remove the SDS. Plugs were prepared for EcoRI cleavage by equilibration in the EcoRI RARE-cleavage buffer (50 mM HEPES, pH 7.0, 150 mM NaCl, 10 mM MgCl 2 , 1 mM dithiothreitol, 500 g/ml acetylated bovine serum albumin). Digestions were then performed in 500l of EcoRI RARE-cleavage buffer plus 50 units of EcoRI enzyme at 37°C overnight. The reaction was stopped by adding EDTA to a final concentration of 50 mM.
Pulse Field Electrophoresis and Southern Blot Analysis of YAC Genomic Clones-After EcoRI digestion, the agarose plugs containing YAC DNA were equilibrated in 0.5ϫ TBE. Plugs were inserted into the wells of a 1% agarose (SeaPlaque) gel, and the gel was run on the Bio-Rad CHEF-DR II pulse field electrophoresis apparatus. The running conditions included a field strength of 6 volts/cm, a switch time of 20 -60 s, a temperature of 14°C, and a running time of 18 h. DNA was then transferred from the gels to a Hybond-N membrane (Amersham Pharmacia Biotech) and analyzed with radiolabeled probes generated by PCR for the coding regions of exon 2 of the human PAR1, PAR2, and PAR3 genes. These probes were generated using the following primer sets. PAR1g: forward, TTGTCCCATCTGTGTACACCG; reverse, GGTCGATGCACGA-GCTTATGC. PAR2g: forward, CCACTGTCTTCCTTCCAATTG; reverse, CAAAGGGGTCGATGCAGCTGT. PAR3g: forward, ACTAAACTGATAC-CTGCCATC; reverse, TGGATCTAAGCAACTATTAAG.
PAR Amino Acid Alignment and Generation of a PAR DendrogramMultiple alignments of the amino acid sequences of the PARs shown were created using protein sequences taken from the National Center for Biotechnology GenBank data base with the GCG9.1 Pileup program (data not shown). The parameters were set to default. The dendrogram was created by Pileup, and the tree was verified with the PaupSearch and PaupDisplay programs from the GCG9.1 package (Wisconsin Package, Version 9.1, Genetics Computer Group).
Chromosomal Localization of the Mouse PAR4 Gene-Fluorescent in situ hybridization was performed by Genome Systems. DNA from BAC 16058 was labeled with digoxigenin dUTP by nick translation. Labeled probe was combined with sheared mouse DNA and hybridized to normal metaphase chromosomes derived from mouse embryo fibroblast cells in a solution containing 50% formamide, 10% dextran sulfate, and 2ϫ SSC. Specific hybridization signals were detected by incubating the hybridized slides in fluoresceinated anti-digoxigenin antibodies followed by counterstaining with 4Ј,6-diamidino-2-phenylindole, HCl. After an initial experiment indicated specific labeling of a chromosome believed to be chromosome 8, a subsequent experiment was performed in which a probe specific for the telomeric region of chromosome 8 (Genome Systems) was co-hybridized with Par4g-containing BAC DNA. Measurements of 10 specifically hybridized copies of chromosome 8 were performed.
RESULTS

Structure of the Genes Encoding PAR3 and PAR4 -Previous
analysis of the genes encoding PAR1 and PAR2 revealed virtually identical structures (3, (23) (24) (25) . In both of these genes in both mouse and human, a short first exon encodes the 5Ј-untranslated sequence, start codon, and signal peptide, and a second, larger exon encodes the mature receptor protein and 3Ј-untranslated sequence. These exons are separated by a 10 -15 kilobase (kb) intron (3).
To characterize the gene encoding mouse PAR3, a BAC from a genomic library previously shown to contain both Par1g and Par2g (3) (Genome Systems clone 8050) was analyzed by PCR and found to contain Par3g. This was confirmed by subsequent Southern analysis (Fig. 1A and data not shown) . A 10-kb fragment of this BAC containing Par3g was subcloned, and the regions surrounding exons 1 and 2 were sequenced to characterize the intron-exon boundaries (Fig. 1A) . The intron was amplified by PCR using specific Par3g exon 1 and exon 2 primers, and its size was determined to be 4.5 kb (Fig. 1 and  data not shown) .
The structure of the human PAR3 gene was determined using a YAC from a human genomic library previously shown to contain the genes encoding PAR1 and PAR2 (3) (Genome Systems clone Y6926). Based on the structure of the mouse gene determined above and using the known human PAR3 cDNA sequence (5), PCR primers to PAR3g exons 1 and 2 were designed and used to amplify from the YAC a product containing the appropriate PAR3g exon 1 and 2 sequences and an intervening intron. This PCR product was sequenced to determine intron-exon junctions (Fig. 1) .
The structures of the mouse and human PAR4 genes were determined using BACs obtained from genomic libraries by PCR screen using primers based on PAR4 cDNA sequences (6, 16) (Genome Systems clone 16058). A 6.5-kb BamHI fragment containing the two murine PAR4 exons was subcloned and sequenced with subsequent identification of a 247-base pair intron separating exons 1 and 2 (Fig. 1) . The human PAR4 intron was determined by PCR using primers based on the position of the mouse gene; it was found in the identical position as the mouse intron, but it was 27 base pairs longer (274 base pairs). Interestingly, although the human and mouse PAR4 genes share considerable amino acid identity throughout the entire receptor, there is a predicted 9-amino acid stretch of the amino terminus of the murine PAR4 receptor for which no corresponding residues exist in the human receptor (Fig. 1) . Because these 9 amino acids are encoded by the sequence immediately 3Ј of the mouse splice acceptor site and the human intron is precisely 27 base pairs longer than the mouse intron, it is likely that the adoption of a distinct 3Ј splice acceptor site in the human gene accounts for both the slightly shortened amino terminus of the human receptor and the slightly lengthened intron of the human PAR4 gene.
These studies revealed that the genes encoding mouse and human PAR3 and PAR4 share the two exon structure described FIG. 1. Genomic structure of the human and mouse protease-activated receptor genes. A, schematic of the structures of mouse and human PAR genes. Exon 1 (X1) encodes the 5Ј-untranslated sequence, start codon, and putative signal peptide, whereas exon 2 (X2) encodes the bulk of the mature receptor protein and 3Ј-untranslated sequence; only the coding region of exon 2 of each receptor is shown. Arrowheads indicate the location encoding the activating proteolytic cleavage site of each receptor protein. The introns for each gene were amplified by PCR with primers to exon 1 and exon 2, sized by gel electrophoresis, subcloned, and sequenced to identify splice junctions. Note the common gene structures but differing intron sizes. B, splice junctions of mouse PAR genes. The genomic exon 1 (top) and exon 2 (bottom) sequences and the cDNA sequence (middle) are shown to indicated splice sites. For reference, the corresponding amino acid sequence is shown; the activating cleavage site is indicated by a slash. C, alignment of the mouse and human PAR4 amino termini. The predicted amino acid sequences of the mouse and human PAR4 receptors were aligned using the Clustal W alignment program (Macvector). Identical amino acids are in boldface type and are shaded in dark gray. Note the 9-amino acid gap in the human sequence at the start of exon 2 following the splice junction. Arrowheads indicate the site of the intron in both genes and the activating proteolytic cleavage site of both receptors.
for the genes encoding PAR1 and PAR2 (Fig. 1) . The position of the single intron found in all four genes is virtually identical and separates signal peptide from mature receptor protein. The activating proteolytic cleavage site is consistently found in exon 2 (Fig. 1) . The sizes of the introns in the PAR3 and PAR4 genes are, however, distinct. Whereas the introns in the mouse and human PAR1 and PAR2 genes span 10 -14 kb, the mouse and human PAR3 genes contain a smaller 4.5-kb intron, and the intron in the mouse PAR4 gene spans only 0.25 kb.
Chromosomal Location of the Mouse PAR3 Gene and Characterization of a Mouse PAR Gene Cluster-The genes encoding PAR1 and PAR2 are both located at chromosome 13D2 in the mouse and at the syntenic locus 5q13 in the human (3, 4) . Moreover, the mouse PAR1 and PAR2 genes were both found on single BAC clones from a mouse genomic library, confirming their close proximity in the mouse genome (3). As described above, PCR of one of these BACs revealed the presence of the gene encoding PAR3, and Southern analysis using probes for Par1g, Par2g, and Par3g indicated that all three genes were present in a single 80-kb BAC clone (Fig. 2) . A single P1 bacteriophage genomic clone contained Par3g and exon 1 but not exon 2 of Par1g, placing Par3g 5Ј of Par1g (data not shown). Characterization of the 80-kb BAC insert that contained the mouse genes encoding PAR1, PAR2, and PAR3 by pulsed field gel electrophoresis and Southern analysis of numerous restriction enzyme digests yielded a map of the locus (Fig. 2 and data not shown). Southern blot analysis of BAC DNA digested with the restriction endonucleases XhoI and/or ClaI using probes specific for 5Ј genomic/exon 1 sequence and exon 2/3Ј-untranslated sequences of Par1g and Par2g, respectively, demonstrated that the genes for PAR1 and PAR2 are arranged in tandem with Par1g 5Ј of Par2g (Fig. 2 and data not shown) . Thus, the mouse PAR gene locus contains Par1g, Par2g, and Par3g, with Par1g located centrally. Of note, the genes encoding the two thrombin receptors, PAR1 and PAR3, are adjacent and are physically very close (within approximately 25 kb).
Chromosomal Location of the Human PAR3 Gene and Characterization of a Human PAR Gene Cluster-The human genes encoding PAR1, PAR2, and PAR3 were found on several single YAC genomic clones, the smallest of which was 360 kb (Ref. 3 and data not shown). Unlike the case in mouse, a single BAC containing the three human PAR genes was not found. We analyzed three PAR2g-containing BACs and three PAR3g-containing BACs with insert sizes of approximately 120 -150 kb for the presence of the other PAR genes using PCR and Southern analysis (data not shown). A single 120-kb BAC was found which had both PAR1g and PAR2g (clone 33P14, a gift from J.-F. Fang, Lawrence Livermore Laboratories). No other PAR genes were found in the PAR3g-containing BACs. Pulsed field gel and Southern analysis of the 360-kb Y6926 following digestion with several rare cutting restriction endonucleases demonstrated either no cutting within the 360-kb insert (e.g. NotI) or the presence of each gene on a distinct fragment following digestion (e.g. XhoI and ClaI) (data not shown).
To analyze the order of the human PAR genes in the human locus, we used RARE cleavage (21, 22) to cut the YAC exclusively at known EcoRI sites flanking PAR1g (5Ј of exon 1 and 3Ј of exon 2). Subsequent pulsed field gel and Southern analysis using probes for exon 2 of the three PAR genes revealed that the order of the human PAR genes is identical to that in the mouse locus: PAR1g is centrally placed, with PAR3g 5Ј of exon 1 of PAR1g and PAR2g 3Ј of exon 2 of PAR1g (Fig. 3) . These data are consistent with a recent report of the genomic structure and locus of PAR3g (26) .
Chromosomal Localization of PAR4, a New Thrombin Receptor, Reveals a New Genomic Locus-The identification of PAR4, a fourth PAR and a third thrombin-responsive receptor, raised the questions of whether the PAR4 gene would reside at the PAR genomic locus described above and of what its evolutionary relationship might be to the previously described PARs. To determine whether the PAR4 gene is located at mouse chromosome 13D2, we first screened the available PAR gene-containing mouse genomic clones for the presence of Par4g using PCR (data not shown). Analysis of six BAC and two P1 bacteriophage genomic clones containing one or more of the first three mouse PAR genes did not reveal the presence of Par4g. Likewise, analysis of a single BAC genomic clone containing Par4g did not reveal any of the other PAR genes (data not shown). These data suggested that Par4g might reside at a locus distinct from 13D2. Indeed, fluorescent in situ hybridization to mouse metaphase chromosomes using the Par4g-containing BAC genomic clone as probe localized Par4g to a new locus at chromosome 8B3.3 (Fig.  4) . Like the murine PAR4 gene, the human PAR4 gene has recently been mapped to 19p12, a chromosomal locus distinct   FIG. 2 . Structure of the mouse genomic locus for PARs 1, 2, and 3. A, Southern blot analysis of an 80-kb BAC containing the mouse genes for PARs 1, 2, and 3. BAC DNA was analyzed by restriction endonuclease digestion, pulsed field gel electrophoresis, and Southern blot using probes for exon 2 and the 3Ј-untranslated sequence of mouse PAR 1, 2, or 3 genes as indicated. For Par1g and Par2g, the probes included only sequence 3Ј of the ClaI site in their respective second exons (see B). A single blot was used for the experiment shown; it was stripped and exposed overnight to ensure complete removal of probe between hybridizations. Note that the Par3g and Par2g probes identified the same 50-kb ClaI fragment in the circular BAC and that the Par3g and Par1g probes identified the same 32-kb XhoI fragment. This experiment was repeated twice with separate blots. Par2g probe to sequence 5Ј of the PAR2 exon 2 (X2) ClaI site identified a ClaI fragment indistinguishable from that identified by the Par1g probe in A (data not shown). Cla, ClaI; Xho, XhoI. B, schematic of the mouse PAR genomic locus. The order and orientation of the mouse PAR genes was determined by numerous Southern blot analyses of a single BAC found to contain all three genes (A and data not shown). The relative locations of the mouse PAR genes and the relative orientation of the Par1g and Par2g exons are shown. Arrows indicate the distance between exon 2 of Par1g and exon 2 of Par2g (30 kb) and maximum possible distance between Par3g exon 2 and exon 1 of Par1g (25 kb is the distance between exon 1 of Par1g and the 5Ј extent of the genomic clone (data not shown)). The orientation of Par3g relative to Par1g was not determined. from the one shared by the first three human PAR genes at 5q13 (16) . The PAR4 gene is the first PAR gene to be found outside the described PAR genomic loci. Whether PAR4 is the lone PAR gene at this location or whether it keeps company with a cluster of unidentified PAR genes is an exciting, unanswered question. The possibility of a second PAR gene cluster is realistic, given the chronology of the PAR gene family evolution suggested by phylogenetic analysis (Fig. 5 and below) .
The Relatedness of the PAR Amino Acid Sequences-The amino acid sequences of the known mouse, human, and Xenopus PARs were compared using a computer-based "phylogenetic" analysis program (Pileup) to generate a PAR family tree (Fig. 5) . As expected, the closest relatives of mouse PARs 1, 2, and 3 are their assigned human orthologues. More interestingly, this amino acid sequence-based analysis groups the PARs in a manner consistent with our observations regarding the structures and locations of the PAR genes and suggests a working model for PAR gene evolution (see under "Discussion").
DISCUSSION
The results presented above reveal the structure of a genomic locus containing the genes encoding PAR1, PAR2, and PAR3 and the existence of a new locus containing the gene encoding PAR4. The dendrogram in Fig. 5 suggests that the genes encoding PAR1 and PAR2 arose from a gene duplication event that was relatively recent in the history of this gene family. Indeed, the genes encoding PAR1 and PAR2 are adjacent in the genome and share a virtually identical structure. Somewhat earlier was a duplication that gave rise to the PAR1/2 and PAR3 branches. Par3g is adjacent to Par1g and shares its overall structure, but the Par3g intron is considerably smaller. Most remote was a gene duplication that gave rise to the PAR4 and PAR1/2/3 branches. Par4g shares a common structure with the other PAR genes, but its intron is remarkably smaller, and its chromosomal location is distinct. The sequence-based relationships depicted in Fig. 5 are thus consistent with the structure and positions of the PAR genes.
The existence of a Xenopus homologue of the PAR1 gene suggests that Par1g and Par2g diverged before the existence of separate mammalian and amphibian lineages. Moreover, PAR4 and PARs 1 and 3 all function as receptors for thrombin, suggesting that a capacity to signal in response to thrombin or a thrombin-like protease predated the divergence of mammals and amphibians considerably. It is possible that this system played a hemostatic role by mediating platelet or thrombocyte activation in early vertebrates. Alternatively, recent studies of PAR1-deficient mice suggests that thrombin signaling plays a role in embryonic development that is independent of platelet   FIG. 3 . Structure of the human genomic locus for PARs 1, 2, and 3. A, RARE cleavage and Southern blot analysis of a YAC containing the human genes for PARs 1, 2, and 3. A 360-kb YAC containing all three human PAR genes was analyzed by RARE cleavage and Southern blot. The YAC was cut selectively at an EcoRI site either 5Ј of PAR1g exon 1 (X1) or 3Ј of PAR1g exon 2 (X2) then analyzed by Southern blot using exon 2 probes for human PAR 1, 2, or 3 genes. The EcoRI site at which the YAC was digested is shown above each lane (A, 5Ј and 3Ј; B, 5ЈR1 and 3ЈR1). The band visible at the top of each lane represents hybridization to uncut YAC (i.e. YAC DNA in which the EcoRI site was not protected from methylation prior to EcoRI digestion). Following cleavage at the 3Ј R1, PAR3g and PAR1g probes identified the same 230-kb fragment. The size difference between this band and the 210-kb band identified by thePAR3g probe after cleavage at 5ЈR1 corresponds to the 18-kb distance between the two EcoRI sites. The same is true for the size difference observed for the bands identified with the PAR2g probe after 3Ј digestion and the PAR1g and PAR2g probes after 5Ј R1 digestion. B, schematic of the human PAR 1, 2, and 3 genomic locus. The relative locations of the human PAR genes are shown. Only the exon orientation of PAR1g could be determined in this analysis. Note that the overall structure of the human locus is identical to that determined for the mouse locus in Fig. 2.   FIG. 4 . Fluorescent in situ hybridization for the mouse PAR4 gene. Mouse metaphase chromosomes were probed with a BAC Par4g genomic clone (green arrow) and with probe for the telomeric region of chromosome 8 (yellow arrow). This result was typical of 10 specifically hybridized copies of chromosome 8. The position of the PAR4 gene is 52% of the distance from the hereochromatic-euchromatic boundary to the telomere of chromosome 8, an area that corresponds to cytogenetic band 8B3.3. The appearance of the centromere-like structure at one end of each chromosome is typical of mouse chromosomes, which are acrocentric and do not have long and short arms.
activation (14) , raising the possibility that PARs and signaling in response to thrombin or thrombin-like proteases may have evolved initially to serve a function unrelated to hemostasis in the usual sense.
The above formulation of PAR evolution suggests that PAR2, a receptor for trypsin and trypsin-like enzymes, such as tryptase, but not thrombin (2, 25) , probably evolved from thrombin receptors. The P1-P4 amino acids of the thrombin cleavage site in the amino-terminal exodomain of PAR1 are the major determinants of receptor specificity. Replacing them with cleavage sites for other proteases switches receptor specificity (27) . Indeed, installing the P1-P4 residues of PAR2 amino-terminal of the tethered ligand of PAR1 yields a functional trypsin receptor. 2 Thus, the proteolytic mechanism of PAR activation affords a ready path for evolving receptors for distinct proteases. How extensive the PAR repertoire is remains to be seen.
As noted in the introduction of this report, PAR1 appears to play an important role in activation of human platelets by thrombin but plays little or no role in mouse platelet activation. PAR3 is critical for normal mouse platelet activation (6), but evidence supporting an important role in human platelets is at present lacking. In contrast to the situation with PAR1 and PAR3, PAR4 appears to play a role in platelets in both species (6) . How might the distinct roles of PAR1 and PAR3 in mouse and human platelets have evolved? The identical structures and relative positions of the PAR genes in the mouse and human PAR1/2/3 locus in addition to simple sequence comparison rule out the trivial explanation that our assignment of PAR orthologues is incorrect, i.e. mouse PAR3 is clearly not the orthologue of human PAR1. Two scenarios seem possible. An ancestral PAR gene that was expressed in platelets may have duplicated en bloc to yield two PAR genes with promoters specifying megakaryocyte expression; regulatory elements specifying megakaryocyte expression of PAR1 may subsequently have been lost in the mouse. Just such a scenario likely explains the distinct expression patterns of cardiac ␣ and ␤-myosin heavy chain (MHC) genes in mouse and human (19, 28) . Like the genes for PAR1 and PAR3, the cardiac ␣-and ␤-MHC genes have identical intron/exon structures, are arranged in tandem, and are separated by only 4 -5 kb in both mouse and human genomes (19, 28) . However, after birth, human ventricular myocytes express only ␤-MHC, but mouse ventricular myocytes express only ␣-MHC. Because the 4 kb of genomic sequence upstream of the murine ␣-MHC gene (which separates it from the ␤-MHC gene) is sufficient to direct expression of a transgene to murine ventricular myocytes (12, 19) , it is likely that differential expression of the MHC genes in the two species has probably resulted from the differential loss of regulatory elements that were originally duplicated with each gene. As an alternative to the scenario described above, regulatory sequences that specify megakaryocyte expression may reside between the adjacent PAR1 and PAR3 genes, and differences in the proximity of such regulatory sequences to the PAR1 or PAR3 promoters or other differences in structures of the mouse and human loci may dictate which gene(s) they act upon. Identification of the regulatory elements involved will be required to distinguish between these possibilities.
Finally, this report describes the structure of a new PAR gene, Par4g. Characterization of this gene, which encodes a new platelet thrombin receptor, provided a reagent that will be critical for developing mouse models to define the importance of thrombin signaling in platelets and perhaps other cells. Specifically, it will be necessary to breed mice that are deficient in both PAR3 and PAR4 to determine whether these receptors account for thrombin signaling in mouse platelets and to assess the relative importance of such signaling (6) . Given the suggestion that an early gene duplication gave rise to ancestral PAR4 and PAR1/2/3 genes, the finding that the mouse and human PAR4 genes map to a chromosomal locations distinct from those of the genes encoding PARs 1, 2, and 3 prompts the speculation that the PAR4 locus may contain additional genes encoding novel PARs. YAC and BAC genomic clones containing this locus will provide a ready resource for exploration.
